{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:13:24Z","timestamp":1792602804233,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Grant\u2212in\u2212Aid for Young Scientists B","award":["26861319"],"award-info":[{"award-number":["26861319"]}]},{"name":"Grant-in-Aid for Scientific Research","award":["17"],"award-info":[{"award-number":["17"]}]},{"name":"Grant-in-Aid for Scientific Research","award":["17"],"award-info":[{"award-number":["17"]}]},{"name":"Grant-in-Aid for Scientific Research","award":["17"],"award-info":[{"award-number":["17"]}]},{"DOI":"10.13039\/501100007369","name":"Fukuoka Foundation","doi-asserted-by":"publisher","award":["A4"],"award-info":[{"award-number":["A4"]}],"id":[{"id":"10.13039\/501100007369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007434","name":"Suzuken Memorial Foundation","doi-asserted-by":"publisher","award":["14-044"],"award-info":[{"award-number":["14-044"]}],"id":[{"id":"10.13039\/100007434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bcp.2018.03.008","type":"journal-article","created":{"date-parts":[[2018,3,11]],"date-time":"2018-03-11T00:53:19Z","timestamp":1520729599000},"page":"96-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis"],"prefix":"10.1016","volume":"151","author":[{"given":"Shin","family":"Ishikane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Takahashi-Yanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2018.03.008_b0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bcp.2018.03.008_b0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrc3125","article-title":"Unravelling the complexity of metastasis \u2013 molecular understanding and targeted therapies","volume":"11","author":"Sethi","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"6 Pt 2","key":"10.1016\/j.bcp.2018.03.008_b0015","first-page":"I4","article-title":"Circulating versus local renin-angiotensin system in cardiovascular homeostasis","volume":"77","author":"Dzau","year":"1988","journal-title":"Circulation"},{"issue":"7697","key":"10.1016\/j.bcp.2018.03.008_b0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(71)91085-3","article-title":"Angiotensin II blood-levels in human hypertension","volume":"1","author":"Catt","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2018.03.008_b0025","first-page":"29","article-title":"Inhibition of RAS in diabetic nephropathy","volume":"8","author":"Yacoub","year":"2015","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"issue":"5","key":"10.1016\/j.bcp.2018.03.008_b0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrurol.2010.46","article-title":"Epidemiology and risk factors for kidney cancer","volume":"7","author":"Chow","year":"2010","journal-title":"Nat. Rev. Urol."},{"issue":"18","key":"10.1016\/j.bcp.2018.03.008_b0035","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJM200011023431804","article-title":"Obesity, hypertension, and the risk of kidney cancer in men","volume":"343","author":"Chow","year":"2000","journal-title":"New Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2018.03.008_b0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.medici.2016.03.002","article-title":"Hypertension, serum lipids and cancer risk: a review of epidemiological evidence","volume":"52","author":"Radisauskas","year":"2016","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"4","key":"10.1016\/j.bcp.2018.03.008_b0045","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/HYPERTENSIONAHA.111.189258","article-title":"Blood pressure and risk of cancer incidence and mortality in the metabolic syndrome and cancer project","volume":"59","author":"Stocks","year":"2012","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.bcp.2018.03.008_b0050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archinte.160.3.349","article-title":"Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer","volume":"160","author":"Meier","year":"2000","journal-title":"Archiv. Intern. Med."},{"issue":"11","key":"10.1016\/j.bcp.2018.03.008_b0055","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/sj.bjc.6605955","article-title":"Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine","volume":"103","author":"Nakai","year":"2010","journal-title":"Brit. J. Cancer"},{"issue":"10","key":"10.1016\/j.bcp.2018.03.008_b0060","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/jhh.2009.21","article-title":"Angiotensin inhibition and malignancies: a review","volume":"23","author":"Rosenthal","year":"2009","journal-title":"J. Human Hypertens."},{"issue":"9123","key":"10.1016\/j.bcp.2018.03.008_b0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","article-title":"Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?","volume":"352","author":"Lever","year":"1998","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.bcp.2018.03.008_b0070","doi-asserted-by":"crossref","first-page":"e6394","DOI":"10.1097\/MD.0000000000006394","article-title":"Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: Evidence from a meta-analysis including 55 studies","volume":"96","author":"Sun","year":"2017","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.bcp.2018.03.008_b0075","article-title":"Renin-angiotensin system blockade for the risk of cancer and death","volume":"17","author":"Shen","year":"2016","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"issue":"11","key":"10.1016\/j.bcp.2018.03.008_b0080","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1245\/s10434-015-4436-0","article-title":"Prognostic impact of renin-angiotensin system blockade on renal cell carcinoma after surgery","volume":"22","author":"Miyajima","year":"2015","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2018.03.008_b0085","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/bjc.2011.565","article-title":"Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma","volume":"106","author":"Tanaka","year":"2012","journal-title":"Brit. J. Cancer"},{"issue":"9386","key":"10.1016\/j.bcp.2018.03.008_b0090","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.bcp.2018.03.008_b0095","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","article-title":"Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials","volume":"11","author":"Sipahi","year":"2010","journal-title":"Lancet. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2018.03.008_b0100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cllc.2014.09.006","article-title":"Incidental receipt of cardiac medications and survival outcomes among patients with stage III non-small-cell lung cancer after definitive radiotherapy","volume":"16","author":"Wang","year":"2015","journal-title":"Clin. Lung Cancer"},{"issue":"16","key":"10.1016\/j.bcp.2018.03.008_b0105","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/cncr.30079","article-title":"Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers","volume":"122","author":"Morris","year":"2016","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.bcp.2018.03.008_b0110","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.101497","article-title":"Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies","volume":"183","author":"Yoon","year":"2011","journal-title":"CMAJ: Canad. Med. Assoc. J. = journal de l'Association medicale canadienne"},{"issue":"9455","key":"10.1016\/j.bcp.2018.03.008_b0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)70151-3","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bcp.2018.03.008_b0120","doi-asserted-by":"crossref","first-page":"e57475","DOI":"10.1371\/journal.pone.0057475","article-title":"Metabolic factors associated with risk of renal cell carcinoma","volume":"8","author":"Haggstrom","year":"2013","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.bcp.2018.03.008_b0125","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease","volume":"11","author":"Seeger-Nukpezah","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"19","key":"10.1016\/j.bcp.2018.03.008_b0130","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1002\/cncr.29392","article-title":"Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer","volume":"121","author":"Watkins","year":"2015","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2018.03.008_b0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0031-6997(25)00446-6","article-title":"Angiotensin II receptors and angiotensin II receptor antagonists","volume":"45","author":"Timmermans","year":"1993","journal-title":"Pharmacol. Rev."},{"issue":"6 Pt 1","key":"10.1016\/j.bcp.2018.03.008_b0140","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/ajh\/5.6.406","article-title":"Angiotensin II receptor subtypes","volume":"5","author":"Timmermans","year":"1992","journal-title":"Am. J. Hypertens."},{"issue":"6","key":"10.1016\/j.bcp.2018.03.008_b0145","doi-asserted-by":"crossref","first-page":"H2337","DOI":"10.1152\/ajpheart.2001.281.6.H2337","article-title":"Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide","volume":"281","author":"Berry","year":"2001","journal-title":"Am. J. Physiol. Heart Circul. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2018.03.008_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1043-2760(99)00205-2","article-title":"Signal transduction from the angiotensin II AT2 receptor","volume":"11","author":"Nouet","year":"2000","journal-title":"Trends Endocrinol. Metabol: TEM"},{"key":"10.1016\/j.bcp.2018.03.008_b0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-4899-0952-7_12","article-title":"Angiotensin II in cell growth and matrix production","volume":"377","author":"Hsueh","year":"1995","journal-title":"Adv. Experim. Med. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2018.03.008_b0160","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","article-title":"Inflammation and angiotensin II","volume":"35","author":"Suzuki","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2018.03.008_b0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1172\/JCI16645","article-title":"Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth","volume":"112","author":"Egami","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.bcp.2018.03.008_b0170","doi-asserted-by":"crossref","first-page":"C267","DOI":"10.1152\/ajpcell.00138.2011","article-title":"Angiotensin II increases the permeability and PV-1 expression of endothelial cells","volume":"302","author":"Bodor","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"13","key":"10.1016\/j.bcp.2018.03.008_b0175","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1158\/0008-5472.CAN-04-4653","article-title":"Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells","volume":"65","author":"Dimitroff","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2018.03.008_b0180","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.exer.2013.10.001","article-title":"Low shear stress up-regulation of proinflammatory gene expression in human retinal microvascular endothelial cells","volume":"116","author":"Ishibazawa","year":"2013","journal-title":"Experim. Eye Res."},{"issue":"2","key":"10.1016\/j.bcp.2018.03.008_b0185","doi-asserted-by":"crossref","first-page":"C239","DOI":"10.1152\/ajpcell.00036.2003","article-title":"Stimulation of adhesion molecule expression in human endothelial cells (HUVEC) by adrenomedullin and corticotrophin","volume":"286","author":"Hagi-Pavli","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2018.03.008_b0190","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/092986707779941032","article-title":"Endothelial cell adhesion molecules and cancer progression","volume":"14","author":"Kobayashi","year":"2007","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2018.03.008_b0195","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ajpath.2012.10.026","article-title":"Angiotensin II type 1A receptor signaling facilitates tumor metastasis formation through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells","volume":"182","author":"Amano","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2018.03.008_b0200","first-page":"S13","article-title":"Platelets, inflammation and tissue regeneration","volume":"105","author":"Nurden","year":"2011","journal-title":"Thrombosis Haemostasis"},{"issue":"8","key":"10.1016\/j.bcp.2018.03.008_b0205","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1158\/0008-5472.CAN-03-1054","article-title":"Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis","volume":"64","author":"Ludwig","year":"2004","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bcp.2018.03.008_b0210","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1158\/1078-0432.CCR-04-1946","article-title":"Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination","volume":"11","author":"Suganuma","year":"2005","journal-title":"Clin. Cancer Res. Offi. J. Am. Assoc. Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2018.03.008_b0215","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00280-017-3267-z","article-title":"The influence of TNF-alpha and Ang II on the proliferation, migration and invasion of HepG2 cells by regulating the expression of GRK2","volume":"79","author":"Xu","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2018.03.008_b0220","doi-asserted-by":"crossref","first-page":"e35667","DOI":"10.1371\/journal.pone.0035667","article-title":"Angiotensin II facilitates breast cancer cell migration and metastasis","volume":"7","author":"Rodrigues-Ferreira","year":"2012","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.bcp.2018.03.008_b0225","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/jcp.24639","article-title":"Ang II-AT1R increases cell migration through PI3K\/AKT and NF-kappaB pathways in breast cancer","volume":"229","author":"Zhao","year":"2014","journal-title":"J. Cell. Physiol."},{"issue":"31","key":"10.1016\/j.bcp.2018.03.008_b0230","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2174\/092986710793213724","article-title":"Matrix metalloproteinases","volume":"17","author":"Zitka","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"6 Pt A","key":"10.1016\/j.bcp.2018.03.008_b0235","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bbamcr.2016.03.010","article-title":"Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis","volume":"1863","author":"Oh","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bcp.2018.03.008_b0240","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3892\/ijo.2012.1499","article-title":"Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1\/CXCR4 axis in intrahepatic cholangiocarcinoma","volume":"41","author":"Okamoto","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.bcp.2018.03.008_b0245","article-title":"Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK\/EMT pathway","volume":"39","author":"Ping","year":"2017","journal-title":"Tumour Biol. J. Int. Soc. Oncodevelop. Biol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2018.03.008_b0250","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bcp.2018.03.008_b0255","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bcp.2018.03.008_b0260","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM197203022860901","article-title":"Essential hypertension: renin and aldosterone, heart attack and stroke","volume":"286","author":"Brunner","year":"1972","journal-title":"New Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bcp.2018.03.008_b0265","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1158\/1535-7163.MCT-04-0295","article-title":"Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells","volume":"4","author":"Uemura","year":"2005","journal-title":"Mol. Cancer Therap."},{"issue":"2","key":"10.1016\/j.bcp.2018.03.008_b0270","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/carcin\/bgh324","article-title":"Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth","volume":"26","author":"Fujita","year":"2005","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.bcp.2018.03.008_b0275","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-5793(01)02377-8","article-title":"Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist","volume":"495","author":"Fujimoto","year":"2001","journal-title":"FEBS Lett."},{"issue":"15","key":"10.1016\/j.bcp.2018.03.008_b0280","first-page":"4176","article-title":"Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis","volume":"62","author":"Miyajima","year":"2002","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bcp.2018.03.008_b0285","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1007\/s13277-015-3235-3","article-title":"Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer","volume":"36","author":"Arrieta","year":"2015","journal-title":"Tumour Biol. J. Int. Soc. Oncodevelop. Biol. Med."},{"issue":"11","key":"10.1016\/j.bcp.2018.03.008_b0290","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/sj.bjc.6605866","article-title":"Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?","volume":"103","author":"Dolley-Hitze","year":"2010","journal-title":"Brit. J. Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2018.03.008_b0295","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ygyno.2008.02.019","article-title":"Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer","volume":"109","author":"Herr","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2018.03.008_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2010.11.002","article-title":"Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer","volume":"77","author":"Shirotake","year":"2011","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.bcp.2018.03.008_b0305","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00280-009-1136-0","article-title":"Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma","volume":"66","author":"Otake","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2018.03.008_b0310","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/1470320312447649","article-title":"A comparison of the effects of Angiotensin IV on androgen-dependent and androgen-independent prostate cancer cell lines","volume":"14","author":"Dominska","year":"2013","journal-title":"J. Renin-Angiotensin-Aldosterone Syst.: JRAAS"},{"issue":"8","key":"10.1016\/j.bcp.2018.03.008_b0315","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4161\/cbt.6.8.4412","article-title":"Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread","volume":"6","author":"Carl-McGrath","year":"2007","journal-title":"Cancer Biol. Therapy"},{"issue":"4","key":"10.1016\/j.bcp.2018.03.008_b0320","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/1570161043385556","article-title":"Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer","volume":"2","author":"Escobar","year":"2004","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2018.03.008_b0325","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/carcin\/bgn171","article-title":"The renin-angiotensin system and malignancy","volume":"29","author":"Ager","year":"2008","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.bcp.2018.03.008_b0330","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.HYP.0000138688.78906.6b","article-title":"Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling","volume":"44","author":"Zhao","year":"2004","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.bcp.2018.03.008_b0335","first-page":"1139","article-title":"Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor","volume":"2","author":"Uemura","year":"2003","journal-title":"Mol. Cancer Therap."},{"issue":"3","key":"10.1016\/j.bcp.2018.03.008_b0340","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3892\/mmr.2014.1891","article-title":"Angiotensin II promotes the progression of human gastric cancer","volume":"9","author":"Huang","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.bcp.2018.03.008_b0345","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000362092","article-title":"Role of two types of angiotensin II receptors in colorectal carcinoma progression","volume":"81","author":"Zhou","year":"2014","journal-title":"Pathobiol. J. Immunopathol. Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2018.03.008_b0350","first-page":"10","article-title":"Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases","author":"Ager","year":"2010","journal-title":"Cancer Cell Int."},{"issue":"12","key":"10.1016\/j.bcp.2018.03.008_b0355","doi-asserted-by":"crossref","first-page":"e83754","DOI":"10.1371\/journal.pone.0083754","article-title":"Effects of angiotensin II type 2 receptor overexpression on the growth of hepatocellular carcinoma cells in vitro and in vivo","volume":"8","author":"Du","year":"2013","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.bcp.2018.03.008_b0360","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/carcin\/23.7.1235","article-title":"Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis","volume":"23","author":"Takagi","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2018.03.008_b0365","first-page":"10","article-title":"Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice","author":"Doi","year":"2010","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2018.03.008_b0370","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/pros.20738","article-title":"Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines","volume":"68","author":"Chow","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.bcp.2018.03.008_b0375","first-page":"626","article-title":"Angiotensin-(1-7) suppresses hepatocellular carcinoma growth and angiogenesis via complex interactions of angiotensin II type 1 receptor, angiotensin II type 2 receptor and Mas receptor","volume":"21","author":"Liu","year":"2015","journal-title":"Mol. Med. (Cambridge, Mass.)"},{"issue":"1","key":"10.1016\/j.bcp.2018.03.008_b0380","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.bcp.2018.03.008_b0385","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00109-015-1355-2","article-title":"The lung metastatic niche","volume":"93","author":"Maru","year":"2015","journal-title":"J. Mol. Med. (Berlin, Germany)"},{"key":"10.1016\/j.bcp.2018.03.008_b0390","article-title":"Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment","author":"Nakamura","year":"2017","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.bcp.2018.03.008_b0395","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc2945","article-title":"The renin-angiotensin system and cancer: old dog, new tricks","volume":"10","author":"George","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2018.03.008_b0400","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.biochi.2016.09.016","article-title":"H2AK119 monoubiquitination regulates Angiotensin II receptor mediated macrophage infiltration and renal fibrosis in type 2 diabetic rats","volume":"131","author":"Pandey","year":"2016","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.bcp.2018.03.008_b0405","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/jlb.55.3.410","article-title":"Macrophages and angiogenesis","volume":"55","author":"Sunderkotter","year":"1994","journal-title":"J. Leukocyte Biol."},{"issue":"4","key":"10.1016\/j.bcp.2018.03.008_b0410","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00004872-199917040-00012","article-title":"Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages","volume":"17","author":"Okamura","year":"1999","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.bcp.2018.03.008_b0415","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ajpath.2011.11.027","article-title":"Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancer","volume":"180","author":"Shirotake","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2018.03.008_b0420","first-page":"45","article-title":"Targeting the tumor stroma as a novel treatment strategy for breast cancer: shifting from the neoplastic cell-centric to a stroma-centric paradigm","volume":"65","author":"Tchou","year":"2012","journal-title":"Adv. Pharmacol. (San Diego, Calif.)"},{"issue":"8","key":"10.1016\/j.bcp.2018.03.008_b0425","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4161\/cbt.25092","article-title":"The renin angiotensin system regulates Kupffer cells in colorectal liver metastases","volume":"14","author":"Wen","year":"2013","journal-title":"Cancer Biol. Therapy"},{"issue":"4","key":"10.1016\/j.bcp.2018.03.008_b0430","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1440-1746.2006.04797.x","article-title":"Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases","volume":"22","author":"Neo","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.bcp.2018.03.008_b0435","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2174\/1568026043451320","article-title":"Renin-angiotensin system blockade at the level of the angiotensin converting enzyme or the angiotensin type-1 receptor: similarities and differences","volume":"4","author":"Stergiou","year":"2004","journal-title":"Curr. Topics Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2018.03.008_b0440","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.amjcard.2011.03.038","article-title":"Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk","volume":"108","author":"Sipahi","year":"2011","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.bcp.2018.03.008_b0445","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11906-012-0324-1","article-title":"Opportunities for targeting the angiotensin-converting enzyme 2\/angiotensin-(1\u20137)\/mas receptor pathway in hypertension","volume":"15","author":"Fraga-Silva","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"issue":"51","key":"10.1016\/j.bcp.2018.03.008_b0450","doi-asserted-by":"crossref","first-page":"88475","DOI":"10.18632\/oncotarget.19290","article-title":"Angiotensin-(1\u20137) counteracts the transforming effects triggered by angiotensin II in breast cancer cells","volume":"8","author":"Cambados","year":"2017","journal-title":"Oncotarget"},{"issue":"2a","key":"10.1016\/j.bcp.2018.03.008_b0455","first-page":"1011","article-title":"Insulin-regulated aminopeptidase\/placental leucil Aminopeptidase (IRAP\/P-lAP) and angiotensin IV-forming activities are modified in serum of rats with breast cancer induced by N-methyl-nitrosourea","volume":"26","author":"Pilar Carrera","year":"2006","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2018.03.008_b0460","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3317\/jraas.2002.041","article-title":"Cellular targets for angiotensin II fragments: pharmacological and molecular evidence","volume":"3","author":"Vauquelin","year":"2002","journal-title":"J. Renin-Angiotensin-Aldosterone Syst.: JRAAS"},{"issue":"1","key":"10.1016\/j.bcp.2018.03.008_b0465","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/jpet.109.161711","article-title":"The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor\/c-Met inhibitor","volume":"333","author":"Yamamoto","year":"2010","journal-title":"J. Pharmacol. Experim. Therapeut."},{"issue":"2","key":"10.1016\/j.bcp.2018.03.008_b0470","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.peptides.2009.12.003","article-title":"Bradykinin increases the secretion and expression of endothelin-1 through kinin B2 receptors in melanoma cells","volume":"31","author":"Andoh","year":"2010","journal-title":"Peptides"},{"issue":"13","key":"10.1016\/j.bcp.2018.03.008_b0475","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1523\/JNEUROSCI.3825-10.2011","article-title":"Bradykinin promotes the chemotactic invasion of primary brain tumors","volume":"31","author":"Montana","year":"2011","journal-title":"J. Neurosci. Offi. J. Soc. Neurosci."},{"issue":"10","key":"10.1016\/j.bcp.2018.03.008_b0480","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/ijc.28334","article-title":"Arterial hypertension and cancer","volume":"134","author":"Milan","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2018.03.008_b0485","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc072330","article-title":"Home blood-pressure monitoring in patients receiving sunitinib","volume":"358","author":"Azizi","year":"2008","journal-title":"New Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bcp.2018.03.008_b0490","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tem.2005.07.009","article-title":"Angiotensin receptors: a new role in cancer?","volume":"16","author":"Deshayes","year":"2005","journal-title":"Trends Endocrinol. Metab. TEM"},{"issue":"6","key":"10.1016\/j.bcp.2018.03.008_b0495","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1158\/1055-9965.EPI-05-0934","article-title":"The angiotensin II\/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer","volume":"16","author":"Rocken","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prevent."},{"issue":"2","key":"10.1016\/j.bcp.2018.03.008_b0500","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lungcan.2011.01.019","article-title":"Molecular cross-regulation between PPAR-gamma and other signaling pathways: implications for lung cancer therapy","volume":"72","author":"Reka","year":"2011","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"issue":"6","key":"10.1016\/j.bcp.2018.03.008_b0505","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3892\/ijo.2017.4177","article-title":"Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest","volume":"51","author":"Samukawa","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.bcp.2018.03.008_b0510","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/2211-5463.12055","article-title":"Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T-cell leukemia cells","volume":"6","author":"Kozako","year":"2016","journal-title":"FEBS Open Biol."},{"issue":"5","key":"10.1016\/j.bcp.2018.03.008_b0515","doi-asserted-by":"crossref","first-page":"8536","DOI":"10.18632\/oncotarget.14345","article-title":"The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKalpha\/mTOR pathway in vitro and in vivo","volume":"8","author":"Fujihara","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.bcp.2018.03.008_b0520","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10585-012-9480-6","article-title":"Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer","volume":"29","author":"Shimomoto","year":"2012","journal-title":"Clin. Experim. Metastasis"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218301059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218301059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:12:34Z","timestamp":1751479954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218301059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":104,"alternative-id":["S0006295218301059"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.03.008","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}